CN102781466B - 与分泌者血型状态相符的益生双歧杆菌组合物 - Google Patents

与分泌者血型状态相符的益生双歧杆菌组合物 Download PDF

Info

Publication number
CN102781466B
CN102781466B CN201080063735.9A CN201080063735A CN102781466B CN 102781466 B CN102781466 B CN 102781466B CN 201080063735 A CN201080063735 A CN 201080063735A CN 102781466 B CN102781466 B CN 102781466B
Authority
CN
China
Prior art keywords
bifidobacterium
secretor
bifidobacteria
dgge
band positions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080063735.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN102781466A (zh
Inventor
P·瓦克林
J·马托
H·马基沃考
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dupont Nutritional Biosciences
Original Assignee
Suomen Punainen Risti Veripalvelu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalvelu filed Critical Suomen Punainen Risti Veripalvelu
Publication of CN102781466A publication Critical patent/CN102781466A/zh
Application granted granted Critical
Publication of CN102781466B publication Critical patent/CN102781466B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201080063735.9A 2009-12-28 2010-12-28 与分泌者血型状态相符的益生双歧杆菌组合物 Expired - Fee Related CN102781466B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FI20096400 2009-12-28
FI20096400A FI20096400A0 (fi) 2009-12-28 2009-12-28 Veriryhmästatuksen käyttö I
US12/843,404 US20110158950A1 (en) 2009-12-28 2010-07-26 Use of blood group status i
US12/843,404 2010-07-26
PCT/FI2010/051093 WO2011080395A2 (en) 2009-12-28 2010-12-28 Use of blood group status i

Publications (2)

Publication Number Publication Date
CN102781466A CN102781466A (zh) 2012-11-14
CN102781466B true CN102781466B (zh) 2015-11-25

Family

ID=41462858

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080063735.9A Expired - Fee Related CN102781466B (zh) 2009-12-28 2010-12-28 与分泌者血型状态相符的益生双歧杆菌组合物

Country Status (7)

Country Link
US (1) US20110158950A1 (enExample)
EP (1) EP2519255A2 (enExample)
CN (1) CN102781466B (enExample)
BR (1) BR112012016926A2 (enExample)
FI (1) FI20096400A0 (enExample)
IN (1) IN2012DN06393A (enExample)
WO (1) WO2011080395A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012013861A2 (en) * 2010-07-26 2012-02-02 Suomen Punainen Risti Veripalvelu Use of blood group status iii
WO2013154725A1 (en) * 2012-04-13 2013-10-17 Trustees Of Boston College Prebiotic compositions and methods of use
CN105385762A (zh) * 2015-12-10 2016-03-09 扬州市扬大康源乳业有限公司 一种快速鉴定双歧杆菌的方法
EP3419630A4 (en) 2016-02-24 2019-11-06 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101039687A (zh) * 2004-08-05 2007-09-19 安尼德拉尔有限公司 产生叶酸的双岐杆菌菌株，及其制剂和应用
WO2009033011A1 (en) * 2007-09-07 2009-03-12 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826928A1 (de) * 1998-06-17 1999-12-23 Novartis Consumer Health Gmbh Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
WO2001058465A2 (en) * 2000-02-10 2001-08-16 Gregor Reid Probiotic therapy for newborns
WO2003013558A1 (en) * 2001-07-30 2003-02-20 Claudio De Simone Treatment of radiation-induced diarrhea with probiotics
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
RU2445362C2 (ru) * 2006-02-15 2012-03-20 Нестек С.А. Применение bifidobacterium longum в производстве лекарственного средства или терапевтической питательной композиции для лечения воспалительного заболевания кишечника у млекопитающего и для ослабления воспаления кишечника, связанного с пищевыми аллергенами, у млекопитающего
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101039687A (zh) * 2004-08-05 2007-09-19 安尼德拉尔有限公司 产生叶酸的双岐杆菌菌株，及其制剂和应用
WO2009033011A1 (en) * 2007-09-07 2009-03-12 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Human milk glycans protect infants against enteric pathogens;Newburg D S等;《Annual review of nutrition》;20050503;第25卷;第50页第8-13行 *
Two distinct α-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates;Hisashi Ashida等;《Glycobiology》;20090611;第19卷(第9期);第1010-1017页 *

Also Published As

Publication number Publication date
US20110158950A1 (en) 2011-06-30
FI20096400A0 (fi) 2009-12-28
WO2011080395A3 (en) 2011-09-15
EP2519255A2 (en) 2012-11-07
WO2011080395A2 (en) 2011-07-07
CN102781466A (zh) 2012-11-14
IN2012DN06393A (enExample) 2015-10-02
BR112012016926A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
US10967010B2 (en) Compositions comprising bacterial strains
AU2017374767C1 (en) Compositions comprising bacterial strains
EP3377082B1 (en) Compositions comprising bacterial strains
CN102770154B (zh) 与分泌者血型状态相符的益生双歧杆菌组合物
US20130195820A1 (en) Use of blood group status iii
EP2598155A2 (en) Use of blood group status iii
AboNahas et al. Trust your gut: the human gut microbiome in health and disease
US20230302062A1 (en) Compositions comprising bacterial strains
JP2023523221A (ja) 腸内ビフィズス菌の増殖の刺激
CN102781466B (zh) 与分泌者血型状态相符的益生双歧杆菌组合物
Park et al. Comprehensive analysis of the effect of probiotic intake by the mother on human breast milk and infant fecal microbiota
US20120315250A1 (en) Probiotic bifidobacterial composition in accordance with secretor blood group status
US20120301435A1 (en) Probiotic bifidobacterial composition in accordance with secretor blood group status
Selvamani et al. Role of the gut microbiota in the digestive tract diseases
US20130230859A1 (en) Use of blood group status
Korra et al. Trust Your Gut: The Human Gut Microbiome in Health and Disease
Chegdani Effects of Streptococcus thermophilus bacteria on rat gene expression profiles
Bazanella Impact of early life intervention with four Bifidobacterium spp. on the infant faecal microbiota
HK40009862A (en) Compositions comprising a bacterial strain of blautia for use in the treatment of bacterial infections of the gastrointestinal tract
HK40001005A (en) Novel probiotics bifidobacteria strains
HK1260158B (en) Compositions comprising bacterial strains

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: DUBANG NUTRITION BIOSCIENCE COMPANY

Free format text: FORMER OWNER: SUOMEN PUNAINEN RISTI VERIPALVELU

Effective date: 20140731

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20140731

Address after: Copenhagen

Applicant after: DuPont Nutritional Biosciences

Address before: Helsinki

Applicant before: Finnish Blood Red Cross

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151125

Termination date: 20211228

CF01 Termination of patent right due to non-payment of annual fee